Related Experiment Video
Updated: Jul 22, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
A new strategy for improved nicotine vaccines using conformationally constrained haptens
Michael M Meijler1, Masayuki Matsushita, Laurence J Altobell
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Journal of the American Chemical Society
|June 12, 2003
Summary
Synthesizing constrained nicotine analogues and coupling them to KLH significantly boosted antibody production and affinity in mice compared to flexible analogues. This offers a promising avenue for developing more effective nicotine-related immunotherapies.
Area of Science:
- Medicinal Chemistry
- Immunology
- Drug Development
Background:
- Nicotine (C10H14N2) is a psychoactive alkaloid with significant addictive properties.
- Developing effective immunotherapies for nicotine addiction requires potent and specific antibody responses.
- Previous research utilized flexible nicotine haptens, yielding limited immunogenicity.
Purpose of the Study:
- To synthesize novel constrained nicotine analogues.
- To evaluate the immunogenic potential of these constrained analogues compared to flexible ones.
- To assess the resulting antibody titers and affinity for nicotine.
Main Methods:
- Synthesis of constrained nicotine analogues.
- Conjugation of analogues to the keyhole limpet hemocyanin (KLH) carrier protein.
- Immunization of mice with the hapten-carrier conjugates.
- Measurement of antibody titers and affinity using established immunoassays.
Main Results:
- Constrained nicotine analogue conjugates elicited significantly higher antibody titers in immunized mice.
- The antibodies generated demonstrated increased affinity for nicotine compared to those from flexible hapten conjugates.
- KLH conjugation proved effective in enhancing the immunogenicity of the nicotine haptens.
Conclusions:
- Constrained nicotine analogues represent a superior strategy for generating high-titer, high-affinity anti-nicotine antibodies.
- This approach holds potential for the development of novel immunotherapies targeting nicotine addiction.
- The structural rigidity of the hapten is a critical factor in eliciting a robust immune response.
More Related Videos
Related Concept Videos
02:36Chromatin Immunoprecipitation- ChIP
Chromatin immunoprecipitation, or ChIP, is an antibody-based technique used to identify sites on DNA that bind to transcription factors of interest or histone proteins. It also helps determine the type of histone modifications such as acetylation, phosphorylation, or methylation.
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...